Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLX) Research & Development (2022 - 2025)

Scilex Holding has reported Research & Development over the past 4 years, most recently at $8.2 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 274.68% to $8.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.7 million, a 114.81% increase, with the full-year FY2025 number at $20.7 million, up 114.81% from a year prior.
  • Research & Development reached $8.2 million in Q4 2025 per SCLX's latest filing, up from $3.9 million in the prior quarter.
  • The five-year high for Research & Development was $8.2 million in Q4 2025, with the low at $1.2 million in Q3 2022.
  • The 4-year median for Research & Development is $2.7 million (2022), against an average of $3.3 million.
  • Peak YoY movement for Research & Development: tumbled 42.31% in 2024, then surged 274.68% in 2025.
  • Tracing SCLX's Research & Development over 4 years: stood at $2.6 million in 2022, then grew by 5.28% to $2.7 million in 2023, then dropped by 20.26% to $2.2 million in 2024, then surged by 274.68% to $8.2 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $8.2 million, $3.9 million, and $6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.